| 000 | 01585 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514185422.0 | ||
| 264 | 0 | _c20040628 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a0889-2229 | ||
| 024 | 7 |
_a10.1089/088922204322996509 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGonzález de Requena, Daniel | |
| 245 | 0 | 0 |
_aPrediction of virological response to lopinavir/ritonavir using the genotypic inhibitory quotient. _h[electronic resource] |
| 260 |
_bAIDS research and human retroviruses _cMar 2004 |
||
| 300 |
_a275-8 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHIV Infections _xvirology |
| 650 | 0 | 4 |
_aHIV Protease _xdrug effects |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xpharmacokinetics |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLopinavir |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 |
_aPyrimidinones _xpharmacokinetics |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 |
_aRitonavir _xpharmacokinetics |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aGallego, Oscar | |
| 700 | 1 | _aValer, Luisa | |
| 700 | 1 | _aJiménez-Nácher, Inmaculada | |
| 700 | 1 | _aSoriano, Vincent | |
| 773 | 0 |
_tAIDS research and human retroviruses _gvol. 20 _gno. 3 _gp. 275-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/088922204322996509 _zAvailable from publisher's website |
| 999 |
_c14828020 _d14828020 |
||